The research team of Prof. Wanliang Lu has made progress in the study of recombinant virus-like biologics for gene therapy

Journal of Chinese Pharmaceutical Sciences ›› 2023, Vol. 32 ›› Issue (8): 688-690.

The research team of Prof. Wanliang Lu has made progress in the study of recombinant virus-like biologics for gene therapy

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2023-08-15 Revised:2023-08-16 Accepted:2023-08-16 Online:2023-08-31 Published:2023-09-03

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lu has made progress in the study of recombinant virus-like biologics for gene therapy[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 688-690.

The research team of Prof. Wanliang Lu has made progress in the study of recombinant virus-like biologics for gene therapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments